| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/0016-5085(95)90033-0 |
| P8608 | Fatcat ID | release_oek6v6qnwre75g5ldh27ep2ix4 |
| P698 | PubMed publication ID | 7806050 |
| P2093 | author name string | Hay JE | |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bone disease | Q4941552 |
| P304 | page(s) | 276-283 | |
| P577 | publication date | 1995-01-01 | |
| P1433 | published in | Gastroenterology | Q4039279 |
| P1476 | title | Bone disease in cholestatic liver disease | |
| P478 | volume | 108 |
| Q35837039 | A case of severe osteomalacia caused by Tubulointerstitial nephritis with Fanconi syndrome in asymptomotic primary biliary cirrhosis. |
| Q73700076 | A controlled trial of calcitonin therapy for the prevention of post-liver transplantation atraumatic fractures in patients with primary biliary cirrhosis and primary sclerosing cholangitis |
| Q55090038 | A study on OPG/RANK/RANKL axis in osteoporotic bile duct-ligated rats and the involvement of nitrergic and opioidergic systems. |
| Q37322123 | Cholestasis and metabolic bone disease - a clinical review |
| Q35198531 | Clinical evaluation for osteoporosis |
| Q89702545 | Comb Atrophy after Bile Duct Ligation in Chickens |
| Q38055205 | Current pharmacotherapy for cholestatic liver disease |
| Q43507801 | Effects of IGF-I treatment on osteopenia in rats with advanced liver cirrhosis. |
| Q34666342 | Effects of cirrhosis on bone mineral density and bone metabolism |
| Q44173814 | Effects of total bilirubin on the prevalence of osteoporosis in postmenopausal women without potential liver disease |
| Q73330566 | Etidronate for osteoporosis in primary biliary cirrhosis: a randomized trial |
| Q27004571 | Hepatic osteodystrophy |
| Q46795938 | Hepatic osteodystrophy: does the osteoprotegerin/receptor activator of nuclear factor-kB ligand system play a role? |
| Q36031673 | Increased risk of hip fracture associated with dually treated HIV/hepatitis B virus coinfection |
| Q35159007 | Iron interactions and other biological reactions mediating the physiological and toxic actions of manganese |
| Q36506087 | Liver disease and osteoporosis. |
| Q38002368 | Long-term outcome after liver transplantation |
| Q44513824 | Low body mass index and use of corticosteroids, but not cholestasis, are risk factors for osteoporosis in patients with chronic liver disease |
| Q80839481 | Nutritional status of infants with neonatal cholestasis |
| Q58817411 | Osteopenia in rats with liver cirrhosis: beneficial effects of IGF-I treatment |
| Q94415399 | Osteoporosis |
| Q38723451 | Osteoporosis across chronic liver disease. |
| Q37085238 | Osteoporosis and fractures in HIV/hepatitis C virus coinfection: a systematic review and meta-analysis. |
| Q26824690 | Osteoporosis and fractures in liver disease: relevance, pathogenesis and therapeutic implications |
| Q89538006 | Osteoporosis in Primary Biliary Cholangitis: Prevalence, Impact and Management Challenges |
| Q51623988 | Osteoporosis in chronic liver disease: a case-control study. |
| Q35134421 | Osteoporosis in liver diseases and after liver transplantation |
| Q57168372 | Osteoporosis in primary biliary cholangitis |
| Q35354549 | Predicting bone loss following orthotopic liver transplantation |
| Q46351576 | Primary biliary cirrhosis and osteoporosis: a case-control study |
| Q34210604 | Primary biliary cirrhosis and primary sclerosing cholangitis |
| Q35573894 | Primary biliary cirrhosis—presentation and diagnosis |
| Q46653540 | Quercetin improves bone strength in experimental biliary cirrhosis. |
| Q35011138 | Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection |
| Q77803126 | Rheumatologic manifestations of gastrointestinal diseases |
| Q36208036 | Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection |
| Q34670561 | Risk of hip fracture associated with untreated and treated chronic hepatitis B virus infection |
| Q44723222 | Testicular atrophy after bile duct ligation in chickens |
| Q44593072 | The heterogeneity of bone disease in cirrhosis: a multivariate analysis |
| Q33722412 | Viral hepatitis is associated with reduced bone mineral density in HIV-infected women but not men |
| Q36666317 | Vitamin D replacement for cirrhosis-related bone disease |
| Q73302312 | Vitamin D-receptor genotypes as independent genetic predictors of decreased bone mineral density in primary biliary cirrhosis |
Search more.